Tag: Roche

Lonza to acquire Genentech’s biologics manufacturing facility in Vacaville for $1.2bn

businessnewstoday- March 20, 2024

In a strategic move that significantly escalates its capacity in the biologics manufacturing landscape, Lonza, a key global player in manufacturing for the pharmaceutical, biotech, ... Read More

Roche to acquire LumiraDx’s Point of Care technology for $350m to expand diagnostics reach

businessnewstoday- January 1, 2024

Roche has announced a definitive agreement to acquire select parts of LumiraDx Group related to its innovative Point of Care technology, a deal totaling $350 ... Read More

NiKang Therapeutics, Roche partner for advanced liver cancer treatment trial

businessnewstoday- December 9, 2023

NiKang Therapeutics Inc., a clinical-stage biotech company specializing in small molecule oncology medicines, has announced a significant clinical trial collaboration and supply agreement with F. ... Read More

Genentech’s Phase 3 study of inavolisib in breast cancer reveals positive results

businessnewstoday- December 9, 2023

Genentech, part of the Roche Group, has presented compelling results from the Phase III INAVO120 study, evaluating the effectiveness of inavolisib in combination with palbociclib ... Read More

Roche’s inavolisib meets primary endpoint of PFS in Phase 3 breast cancer trial

businessnewstoday- December 6, 2023

Roche, a global leader in pharmaceuticals, announced positive results from its Phase III INAVO120 study, testing the investigational therapy inavolisib in combination with palbociclib (Ibrance) ... Read More

Roche to acquire Carmot Therapeutics to expand obesity treatment portfolio

businessnewstoday- December 6, 2023

Roche announced its definitive agreement to acquire Carmot Therapeutics, Inc., based in Berkeley, California, for an upfront purchase price of USD 2.7 billion, with additional ... Read More

PsychoGenics secures license for ENT1 inhibitor RO7117997 from Roche

businessnewstoday- December 3, 2023

PGI Drug Discovery LLC (PsychoGenics), recognized for its phenotypic drug discovery platform, has announced an exclusive license agreement with Roche. This agreement grants PsychoGenics global ... Read More

Roche’s Vabysmo gains FDA approval for treating retinal vein occlusion

businessnewstoday- October 28, 2023

Pharma giant Roche has secured the U.S. FDA's approval for Vabysmo (faricimab) in treating macular edema after retinal vein occlusion (RVO). This becomes the third ... Read More

Roche announces $7.1bn deal to acquire Telavant and RVT-3101 antibody

businessnewstoday- October 23, 2023

Switzerland-based Roche has officially declared its acquisition agreement for Telavant Holdings, Inc., a Roivant company collaboratively owned by Roivant Sciences Ltd. and Pfizer Inc. The ... Read More

Roche, Alnylam’s Zilebesiran meets primary endpoint in KARDIA-1 trial

businessnewstoday- September 10, 2023

Breaking news in the world of hypertension treatment, Roche and Alnylam Pharmaceuticals have announced the success of their Phase 2 study KARDIA-1. The investigational RNAi ... Read More